- Home
- TRVI vs AMC Comparison
TRVI vs AMC Comparison
Compare TRVI & AMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRVI | AMC |
|---|---|---|
| Founded | 2011 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | 2019 | 2007 |
Fundamental Metrics
Financial Performance| Metric | TRVI | AMC |
|---|---|---|
| Price | $14.35 | $2.78 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 7 |
| Target Price | ★ $28.18 | $2.95 |
| AVG Volume (30 Days) | 1.3M | ★ 23.4M |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.91 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $4,848,900,000.00 |
| Revenue This Year | N/A | $14.87 |
| Revenue Next Year | N/A | $4.11 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 4.57 |
| 52 Week Low | $9.29 | $0.93 |
| 52 Week High | $20.22 | $3.40 |
Technical Indicators
Market Signals| Indicator | TRVI | AMC |
|---|---|---|
| Relative Strength Index (RSI) | 31.99 | 55.47 |
| Support Level | $14.00 | $2.34 |
| Resistance Level | $14.75 | $2.93 |
| Average True Range (ATR) | 0.53 | 0.17 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 19.82 | 50.01 |
Price Performance
Historical ComparisonAbout TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.
About AMC AMC Entertainment Holdings Inc.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. The company owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.